PDF herunterladen
Thromb Haemost 1977; 38(04): 0874-0880
DOI: 10.1055/s-0038-1651905
Original Article
Schattauer GmbH

Plasma Antithrombin III and Factor VIII Antigen in Relation to Angiographic Findings, Angina and Blood Groups in Middle-Aged Men

Helge Stormorken
1   Institute for Thrombosis Research and Medical Department B, Rikshospitalet, Oslo 1, Norway
,
Jan Erikssen
1   Institute for Thrombosis Research and Medical Department B, Rikshospitalet, Oslo 1, Norway
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. Juli 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

In a prospective study on latent coronary heart disease (CHD) in 2,014 presumably healthy men aged 40–59 years, 115 had strong clinical evidence of CHD never diagnosed nor suspected prior to the survey. Coronary angiography was performed in 105 of these. In 80 of them – whereof 57 were angiopositive and 23 angionegative – AT III and factor VIII Ag were assayed as well as in 35 normals from the same material. The results showed that:

1. AT III was significantly lower in the angiopositive than in the normal controls.

2. Subdivision of the angiopositive into those with and those without angina pectoris revealed significantly lower level of AT III in the former.

3. Within blood group A only did the angiopositive subjects have significantly lower AT III than the remaining subjects in the group, and this was entirely due to the low values in those with angina pectoris.

4. Blood group 0 individuals had significantly lower factor VIII Ag level than all other blood groups.

The significance of these findings for the possible relation to development of atheromatosis is briefly discussed.

 

  • References

  • 1 Astrup T. 1958; The haemostatic balance. Thrombosis et Diathesis Haemorrhagica 2: 347.
    PubMedGoogle Scholar
  • 2 Chandler A. B. 1970. Thrombosis and development of atherosclerotic lesions. In: Jones R. J. (ed.) Atherosclerosis. Springer Verlag; New York: 88.
    Google Scholar
  • 3 Duguid J. B. 1948; Thrombosis as a factor in the pathogenesis of aortic atherosclerosis. Journal of Pathology and Bacteriology 60: 57.
    CrossrefPubMedGoogle Scholar
  • 4 Egeberg O. 1965; Inherited anti thrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 13: 516.
    PubMedGoogle Scholar
  • 5 Erikssen J, Enger S. Chr. (in press): Smoking, lung function, physical performance and latent coronary heart disease in presumably healthy middle aged men. Acta Medica Scandinavica..
    PubMedGoogle Scholar
  • 6 Erikssen J, Enge L, Forfang K, Storstein O. 1976; False positive diagnostic tests and coronary angiographic findings in 105 presumably healthy men. Circulation 54: 371.
    CrossrefPubMedGoogle Scholar
  • 7 Erikssen J, Forfang K, Storstein O. 1977 Angina pectoris in presumably healthy men. Validation of two questionnaires in making the diagnosis of angina pectoris. European Journal of Cardiology..
    PubMedGoogle Scholar
  • 8 Fagerhol M. K, Abildgaard U, Kornstad L. 1971; Antithrombin III concentration and ABO blood groups. Lancet II: 664.
    PubMedGoogle Scholar
  • 9 Innerfield I, Gold-Fischer J. D, Reicher-Reiss Greenbag J. 1976; Serum antithrombin in coronary artery disease. American Journal of Clinical Pathology 65: 64.
    CrossrefPubMedGoogle Scholar
  • 10 Korsan-Bengtsen K, Wilhelmsen L, Nilsson L.-A, Tibblin G. 1972; Blood coagulation and fibrinolysis in relation to ABO, MN and Duffy blood group in a random population sample of men 54 years. Thrombosis Research 1: 549.
    CrossrefPubMedGoogle Scholar
  • 11 Laurell C.-B. 1972; Electroimmunoassay. Scandinavian Journal of Clinical and Laboratory Investigation 29 (Suppl. 124) 21.
    CrossrefPubMedGoogle Scholar
  • 12 Mannucci P. M, Pareti F. L, Holmberg L, Nilsson I. M, Ruggeri Z. M. 1976; Studies on the prolonged bleeding time in von Willebrand’s disease. Journal of Laboratory and Clinical Medicine 88: 662.
    PubMedGoogle Scholar
  • 13 Meade T. W. 1968; The epidemiology of ischaemic heart disease. Transaction of Social and Occupational Medicine 18: 127.
    PubMedGoogle Scholar
  • 14 Medalie J. H, Gouldbourt U. 1976; Unrecognized myocardial infarction: Five year incidence, mortality and risk factors. Annals of Internal Medicine 84: 526.
    CrossrefPubMedGoogle Scholar
  • 15 Mustard J. F, Packham M. A. 1975; The role of blood and platelets in atherosclerosis and the complications of atherosclerosis. Thrombosis et Diathesis Haemorrhagica 33: 444.
    PubMedGoogle Scholar
  • 16 Oedegaard O. R, Lie M, Abildgaard U. 1975; Heparin cofactor activity measured with an amidolytic method. Thrombosis Research 6: 287.
    CrossrefPubMedGoogle Scholar
  • 17 Silwer J, Cronberg S, Nilsson I. M. 1966; Occurrence of arteriosclerosis in von Willebrand’s disease. Acta Medica Scandinavica 180: 474.
    PubMedGoogle Scholar
  • 18 Stormorken H, Erikssen J, Hellem A, Nitter-Hauge S. 1977. Studies on some tests of possible value in heralding arterial thrombosis. In: The significance of platelet function tests in the evaluation of haemostatic and thrombotic tendencies. US Government Press; in print.
    Google Scholar
  • 19 Tschopp T, Weiss H. J, Baumgartner H. R. 1974; Decreased adhesion of platelets to subendothelium in von Willebrand’s disease. Journal of Laboratory and Clinical Medicine 83: 296.
    PubMedGoogle Scholar
  • 20 Vessey M. P. 1973. The epidemiology of venous thromboembolism. In: Recent Advances in Thrombosis. Poller L. (ed.) Churchill-Livingstone; London: 1973: 39.
    Google Scholar
  • 21 Warren J. W. 1973; A revolution in coronary artery disease. Journal of Chronic Diseases 26: 547.
    CrossrefPubMedGoogle Scholar